- Home
- HVT vs IMRX Comparison
HVT vs IMRX Comparison
Compare HVT & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HVT | IMRX |
|---|---|---|
| Founded | 1885 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.1M | 366.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HVT | IMRX |
|---|---|---|
| Price | $26.36 | $5.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.20 |
| AVG Volume (30 Days) | 71.2K | ★ 3.1M |
| Earning Date | 02-23-2026 | 11-12-2025 |
| Dividend Yield | ★ 4.92% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $741,429,000.00 | N/A |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | $8.12 | N/A |
| P/E Ratio | $22.88 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.01 | $1.10 |
| 52 Week High | $27.46 | $10.08 |
Technical Indicators
Market Signals| Indicator | HVT | IMRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 48.78 |
| Support Level | $25.52 | $4.35 |
| Resistance Level | $27.46 | $4.90 |
| Average True Range (ATR) | 0.87 | 0.60 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 71.13 | 32.21 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.